BANK OF MONTREAL /CAN/ - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 74 filers reported holding OCULAR THERAPEUTIX INC in Q3 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2023$936,587
-56.7%
181,509
-64.5%
0.00%
-100.0%
Q2 2022$2,162,000
+100.2%
511,195
+142.3%
0.00%0.0%
Q1 2022$1,080,000
+1828.6%
210,937
+6109.5%
0.00%
Q1 2021$56,000
-77.8%
3,397
-70.9%
0.00%
Q4 2020$252,000
+769.0%
11,662
+237.7%
0.00%
Q3 2020$29,000
-19.4%
3,453
-27.2%
0.00%
Q2 2020$36,000
+1100.0%
4,744
+633.2%
0.00%
Q1 2020$3,000
-87.5%
647
-89.2%
0.00%
Q4 2019$24,000
-80.5%
5,976
-85.2%
0.00%
Q3 2019$123,000
-30.1%
40,483
+1.4%
0.00%
Q2 2019$176,00039,907
+46303.5%
0.00%
Q1 2019$0
-100.0%
86
-82.1%
0.00%
Q4 2018$2,000
-98.7%
480
-97.8%
0.00%
Q3 2018$151,000
+1.3%
21,950
+0.0%
0.00%
Q2 2018$149,000
-16.3%
21,948
-19.8%
0.00%
Q1 2018$178,000
+57.5%
27,375
+7.5%
0.00%
Q4 2017$113,000
-56.4%
25,456
-39.5%
0.00%
Q3 2017$259,000
+6.1%
42,084
+60.7%
0.00%
Q2 2017$244,000
+18.4%
26,182
+18.0%
0.00%
Q1 2017$206,000
-5.1%
22,182
-4.8%
0.00%
Q4 2016$217,000
+21600.0%
23,308
+11381.8%
0.00%
Q3 2016$1,000
-97.9%
203
-95.9%
0.00%
Q1 2016$48,000
+585.7%
5,000
+579.3%
0.00%
Q4 2015$7,0007360.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2017
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders